These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28440126)

  • 21. TCD in sickle cell disease: an important and useful test.
    Adams RJ
    Pediatr Radiol; 2005 Mar; 35(3):229-34. PubMed ID: 15703904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing.
    Nichols FT; Jones AM; Adams RJ
    J Neuroimaging; 2001 Oct; 11(4):354-62. PubMed ID: 11677874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation.
    Bulas DI; Jones A; Seibert JJ; Driscoll C; O'Donnell R; Adams RJ
    Pediatr Radiol; 2000 Nov; 30(11):733-8. PubMed ID: 11100487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10-year longitudinal study on the SPPIBA cohort.
    Lagunju IA; Labaeka A; Ibeh JN; Orimadegun AE; Brown BJ; Sodeinde OO
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28906. PubMed ID: 33522690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial Doppler Screening Among Children and Adolescents With Sickle Cell Anemia.
    Reeves SL; Madden B; Freed GL; Dombkowski KJ
    JAMA Pediatr; 2016 Jun; 170(6):550-6. PubMed ID: 27064406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial Doppler Screening Adherence among Children with Sickle Cell Anemia Seen in the Emergency Department.
    Weisman JK; Diamond CE; Kappa S; Nickel RS
    J Pediatr; 2020 Feb; 217():172-176.e1. PubMed ID: 31761430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
    Mack AK; Thompson AA
    J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.
    Wang WC; Gallagher DM; Pegelow CH; Wright EC; Vichinsky EP; Abboud MR; Moser FG; Adams RJ
    J Pediatr Hematol Oncol; 2000; 22(4):335-9. PubMed ID: 10959904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Graziadei G; Casoni FM; Annoni F; Cortinovis I; Ridolfi P; Gandolfi I; Marcon A; Di Pierro E; Cappellini MD
    Ann Hematol; 2017 Sep; 96(9):1547-1555. PubMed ID: 28730452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caregivers' perspectives on barriers to transcranial Doppler screening in children with sickle-cell disease.
    Bollinger LM; Nire KG; Rhodes MM; Chisolm DJ; O'Brien SH
    Pediatr Blood Cancer; 2011 Jan; 56(1):99-102. PubMed ID: 20842753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents - Selected U.S. States, 2019.
    Schieve LA; Simmons GM; Payne AB; Abe K; Hsu LL; Hulihan M; Pope S; Rhie S; Dupervil B; Hooper WC
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1241-1246. PubMed ID: 36173745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between hemoglobin, hemolysis, and transcranial Doppler velocities in children with sickle cell disease: Results from a long-term natural history study in Italy in the era of multimodal therapy.
    Reggiani G; Coppadoro B; Munaretto V; Pieroni A; Viaro F; Manara R; Beaubrun A; Biffi A; Baracchini C; Sainati L; Colombatti R
    Eur J Haematol; 2023 Sep; 111(3):414-422. PubMed ID: 37282348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
    Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.
    Padayachee ST; Thomas N; Arnold AJ; Inusa B
    Pediatr Radiol; 2012 Apr; 42(4):470-4. PubMed ID: 22002844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
    Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
    Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How I manage sickle cell patients with high transcranial doppler results.
    Brewin J; Kaya B; Chakravorty S
    Br J Haematol; 2017 Nov; 179(3):377-388. PubMed ID: 28771666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.